BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12713868)

  • 1. The effects of early and late administration of inhibitors of inducible nitric oxide synthase in a thioacetamide-induced model of acute hepatic failure in the rat.
    Rahman TM; Hodgson HJ
    J Hepatol; 2003 May; 38(5):583-90. PubMed ID: 12713868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simvastatin for rats with thioacetamide-induced liver failure and encephalopathy.
    Huang HC; Wang SS; Lee FY; Chan CY; Chang FY; Lin HC; Chu CJ; Chen YC; Lee SD
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e236-42. PubMed ID: 17573832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detrimental effects of nitric oxide inhibition on hepatic encephalopathy in rats with thioacetamide-induced fulminant hepatic failure: role of nitric oxide synthase isoforms.
    Chu CJ; Chang CC; Wang TF; Lee FY; Chang FY; Chen YC; Chan CC; Huang HC; Wang SS; Lee SD
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1194-9. PubMed ID: 16824075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of inducible nitric oxide synthase activity prevents liver recovery in rat thioacetamide-induced fibrosis reversal.
    Lukivskaya O; Patsenker E; Lis R; Buko VU
    Eur J Clin Invest; 2008 May; 38(5):317-25. PubMed ID: 18380797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detrimental effects of nitric oxide inhibition on hepatic encephalopathy in rats with thioacetamide-induced fulminant hepatic failure.
    Chu CJ; Wang SS; Lee FY; Chang FY; Lin HC; Hou MC; Chan CC; Wu SL; Chen CT; Huang HC; Lee SD
    Eur J Clin Invest; 2001 Feb; 31(2):156-63. PubMed ID: 11168455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hydroxyl radical scavengers dimethylsulfoxide and dimethylthiourea protect rats against thioacetamide-induced fulminant hepatic failure.
    Bruck R; Aeed H; Shirin H; Matas Z; Zaidel L; Avni Y; Halpern Z
    J Hepatol; 1999 Jul; 31(1):27-38. PubMed ID: 10424280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation.
    Salvemini D; Wang ZQ; Wyatt PS; Bourdon DM; Marino MH; Manning PT; Currie MG
    Br J Pharmacol; 1996 Jun; 118(4):829-38. PubMed ID: 8799551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic administration of aminoguanidine reduces vascular nitric oxide production and attenuates liver damage in bile duct-ligated rats.
    Wei CL; Hon WM; Lee KH; Khoo HE
    Liver Int; 2005 Jun; 25(3):647-56. PubMed ID: 15910502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual role for nitric oxide in dynorphin spinal neurotoxicity.
    Hu WH; Li F; Qiang WA; Liu N; Wang GQ; Xiao J; Liu JS; Liao WH; Jen MF
    J Neurotrauma; 1999 Jan; 16(1):85-98. PubMed ID: 9989468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity.
    Handy RL; Moore PK
    Br J Pharmacol; 1998 Mar; 123(6):1119-26. PubMed ID: 9559895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide synthases inhibition results in renal failure improvement in cirrhotic rats.
    Islas-Carbajal MC; Covarrubias A; Grijalva G; Alvarez-Rodríguez A; Armendáriz-Borunda J; Rincón-Sánchez AR
    Liver Int; 2005 Feb; 25(1):131-40. PubMed ID: 15698410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the nitric oxide synthase inhibitors N(G)-nitro-L-arginine methyl ester and aminoethyl-isothiourea on the liver microcirculation in rat endotoxemia.
    Corso CO; Gundersen Y; Dörger M; Lilleaasen P; Aasen AO; Messmer K
    J Hepatol; 1998 Jan; 28(1):61-9. PubMed ID: 9537865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin ameliorates acute thioacetamide-induced hepatotoxicity.
    Shapiro H; Ashkenazi M; Weizman N; Shahmurov M; Aeed H; Bruck R
    J Gastroenterol Hepatol; 2006 Feb; 21(2):358-66. PubMed ID: 16509859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemic tolerance in skeletal muscle: role of nitric oxide.
    Pudupakkam S; Harris KA; Jamieson WG; DeRose G; Scott JA; Carson MW; Schlag MG; Kvietys PR; Potter RF
    Am J Physiol; 1998 Jul; 275(1):H94-9. PubMed ID: 9688900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoactive systems in L-NAME hypertension: the role of inducible nitric oxide synthase.
    Pechánová O; Dobesová Z; Cejka J; Kunes J; Zicha J
    J Hypertens; 2004 Jan; 22(1):167-73. PubMed ID: 15106808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manipulation of the L-arginine-nitric oxide pathway in airway inflammation induced by diesel exhaust particles in mice.
    Takano H; Lim HB; Miyabara Y; Ichinose T; Yoshikawa T; Sagai M
    Toxicology; 1999 Nov; 139(1-2):19-26. PubMed ID: 10614685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock.
    Wu CC; Chen SJ; Szabó C; Thiemermann C; Vane JR
    Br J Pharmacol; 1995 Apr; 114(8):1666-72. PubMed ID: 7541282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of nitric oxide synthases, but not inducible nitric oxide synthase, selectively worsens left ventricular function after successful resuscitation from cardiac arrest in swine.
    Dokken BB; Gaballa MA; Hilwig RW; Berg RA; Kern KB
    Acad Emerg Med; 2015 Feb; 22(2):197-203. PubMed ID: 25639298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inducible nitric oxide synthase inhibitors prolonged the survival of skin xenografts through selective down-regulation of pro-inflammatory cytokine and CC-chemokine expressions.
    Kim JY; Kim D; Lee EM; Choi I; Park CG; Kim KS; Ha J; Kim SJ; Yang J; Kim YS; Han JS; Kim S; Lee JS; Ahn C
    Transpl Immunol; 2003; 12(1):63-72. PubMed ID: 14551033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of nitric oxide synthase inhibitors on lipid peroxide formation in liver caused by endotoxin challenge.
    Sakaguchi S; Furusawa S; Yokota K; Sasaki K; Takayanagi M; Takayanagi Y
    Pharmacol Toxicol; 2000 Apr; 86(4):162-8. PubMed ID: 10815749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.